Fig. 4From: Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine developmentIdentification of immune subtypes of LGG based on the expression of IRDEGs. A Consensus clustering CDF for k = 2 to k = 9. B Relative change in area under CDF curve for k = 2 to k = 9. C Consensus clustering matrix of 529 TCGA-LGG samples for k = 3. D Survival analysis between OS and three groups. E The difference of TMB changes between IS1, IS2, and IS3. F The difference analysis of mRNAsi on different groups. G Difference analysis of clinicopathological characteristics and expression level of OS-related potential LGG antigens in different subgroups. Distribution ratio of IS1-IS3 across LGG H fustat, I gender, J IDH mutation status, K 1p19q co-deletion status, L grade and M age groups (> 45 vs. < = 45) in TCGA-LGG. Fustat, survival statusBack to article page